Photo detail

Alan Auerbach

Stories this photo appears in:

Puma Bio Shares Soar After Tripling Q4 Earnings From Cancer Drug Sales

Puma Biotechnology Inc., a biotech company based in West Los Angeles, announced March 1 it had tripled its year-over-year fourth quarter earnings to $61 million on sales of its signature breast cancer drug.

Tease photo

Puma Breast Cancer Drug Shows Success in Trial

Puma Biotechnology’s flagship drug has been shown to reduce the risk of breast cancer, recurring disease or death in women who have taken it five years, according to a new study.

Tease photo

Puma Biotech Gets $100M Loan to Boost Breast Cancer Drug

Puma Biotechnology has received up to $100 million in term loan funding to support the research and sale of a breast cancer drug approved this summer.

Tease photo

Small Cap, Big Pay

Special Report: Executive Compensation

Chief executives at small-cap companies stocked up on fatter paychecks as the markets’ recovery broadened.

Tease photo